Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Vomiting 4Nausea 4Breast Neoplasms 3Neoplasms 2Lung Neoplasms 1

Interventions

Dexamethasone 51Aprepitant 39Palonosetron 37Ondansetron 31Granisetron 22Calcium Dobesilate 14fosaprepitant 13Olanzapine 12Therapeutics 8dexamethasone acetate 7ramosetron 6casopitant 6Tropisetron 6Cyclophosphamide 6netupitant, palosentron drug combination 5dexamethasone 21-phosphate 5Radiotherapy 5Metoclopramide 5Doxorubicin 5netupitant 4dolasetron 4Dronabinol 4Acupressure 4Yoga 3Vincristine 3Tablets 3Surveys and Questionnaires 3Psychiatric Rehabilitation 3Prochlorperazine 3Lorazepam 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Vomiting × netupitant × Clear all
NCT03204279 2024-06-25

CINV

Helsinn Healthcare SA

Phase 2 Completed
67 enrolled 12 charts

Vomiting

NCT03040726 2023-10-17

Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2/3 Completed
53 enrolled 15 charts

Nausea, Neoplasms, Vomiting

NCT04201769 2020-04-03

LUNG-NEPA

Consorzio Oncotech

Phase 3 Unknown
261 enrolled
Thoracic

Lung Neoplasms, Nausea, Vomiting

NCT03862144 2019-03-05

GIM15-NEPA

Consorzio Oncotech

Phase 2 Completed
150 enrolled
Breast

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡